Literature DB >> 29190256

Time to aortic occlusion: It's all about access.

Anna Romagnoli1, William Teeter, Jason Pasley, Peter Hu, Melanie Hoehn, Deborah Stein, Thomas Scalea, Megan Brenner.   

Abstract

INTRODUCTION: Resuscitative endovascular balloon occlusion of the aorta (REBOA) is a less invasive method of proximal aortic occlusion compared with resuscitative thoracotomy with aortic cross-clamping (RTACC). This study compared time to aortic occlusion with REBOA and RTACC, both including and excluding time required for common femoral artery (CFA) cannulation.
METHODS: This was a retrospective, single-institution review of REBOA or RTACC performed between February 2013 and January 2016. Time of skin incision to aortic cross-clamp for RTACC, time required for CFA cannulation by percutaneous and open methods, and time from guide-wire insertion to balloon inflation at Zone 1 for REBOA, were obtained from videographic recordings.
RESULTS: Eighteen RTACC and 21 REBOAs were performed. Median (Q1, Q3) time from skin incision to aortic cross-clamping was 317 seconds (227, 551 seconds). Median (Q1, Q3) time from start of arterial access to Zone 1 balloon occlusion was 474 seconds (431, 572 seconds) (vs. RTACC, p = 0.01). All REBOA procedures were performed with the same device. The median time to complete CFA cannulation was 247 seconds (range, 164-343 seconds), with no difference between percutaneous or open procedures (p = 0.07). The median (Q1, Q3) time to aortic occlusion in REBOA once arterial access had been established was 245 seconds (179, 295.5 seconds), which was significantly shorter than RTACC (p = 0.003).
CONCLUSIONS: Once CFA access is achieved, time to aortic occlusion is faster with REBOA. Time to aortic occlusion is less than the time required to cannulate the CFA either by percutaneous or open approaches, emphasizing the importance of accurate and expedient CFA access. Resuscitative endovascular balloon occlusion of the aorta may represent a feasible alternative to thoracotomy for aortic occlusion. Time to aortic occlusion will likely decrease with the advent of newer REBOA technology. The rate-limiting portion of REBOA continues to be obtaining CFA access. LEVEL OF EVIDENCE: Therapeutic, level V.

Entities:  

Mesh:

Year:  2017        PMID: 29190256     DOI: 10.1097/TA.0000000000001665

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.313


  19 in total

Review 1.  [Resuscitative endovascular balloon occlusion of the aorta : Bridge to surgery].

Authors:  K Elias; M Engelhardt
Journal:  Unfallchirurg       Date:  2018-07       Impact factor: 1.000

Review 2.  The resuscitative endovascular balloon occlusion of aorta (REBOA) device-what radiologists need to know.

Authors:  Linzi Arndt; Danial Mir; Johnathan Nguyen; Nariman Nezami; Sean R Dariushnia; Laura K Findeiss; Adam Prater; Derek L West; Bill S Majdalany; Nima Kokabi
Journal:  Emerg Radiol       Date:  2019-09-12

3.  Practice, Practice, Practice! Effect of Resuscitative Endovascular Balloon Occlusion of the Aorta Volume on Outcomes: Data From the AAST AORTA Registry.

Authors:  Christina M Theodorou; Jamie E Anderson; Megan Brenner; Thomas M Scalea; Kenji Inaba; Jeremy Cannon; Mark Seamon; M Chance Spalding; Charles J Fox; Ernest E Moore; Joseph J DuBose; Joseph M Galante
Journal:  J Surg Res       Date:  2020-04-17       Impact factor: 2.192

Review 4.  Traumatic Cardiac Arrest: Scoping Review of Utilization of Resuscitative Endovascular Balloon Occlusion of the Aorta.

Authors:  Makoto Aoki; Toshikazu Abe
Journal:  Front Med (Lausanne)       Date:  2022-06-16

5.  Arterial waveform morphomics during hemorrhagic shock.

Authors:  Philip J Wasicek; William A Teeter; Shiming Yang; Peter Hu; William B Gamble; Samuel M Galvagno; Melanie R Hoehn; Thomas M Scalea; Jonathan J Morrison
Journal:  Eur J Trauma Emerg Surg       Date:  2019-04-23       Impact factor: 3.693

Review 6.  Resuscitative endovascular balloon occlusion of the aorta in combat casualties: The past, present, and future.

Authors:  Sarah C Stokes; Christina M Theodorou; Scott A Zakaluzny; Joseph J DuBose; Rachel M Russo
Journal:  J Trauma Acute Care Surg       Date:  2021-08-01       Impact factor: 3.697

7.  Resuscitative endovascular balloon occlusion of the aorta in Canada: a context-specific position paper from the Canadian Collaborative for Urgent Care Surgery (CANUCS).

Authors:  Nori L Bradley; W Robert Leeper; Derek Roberts; Chad G Ball; Andrew Beckett; Paul Engels; Emilie Joos; Kosar Khwaja; Andrew Kirkpatrick; Jacinthe Lampron; Sam Minor; Neil Parry; Joao Neto Rezende; Sandy Widder; Najma Ahmed; Lawrence Gillman; David Gomez; Morad Hameed; Michael Kim; Patrick Murphy; Rahima Nenshi; Timothy Rice; Kelly Vogt
Journal:  Can J Surg       Date:  2022-05-11       Impact factor: 2.840

8.  Joint statement from the American College of Surgeons Committee on Trauma (ACS COT) and the American College of Emergency Physicians (ACEP) regarding the clinical use of Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA).

Authors:  Megan Brenner; Eileen M Bulger; Debra G Perina; Sharon Henry; Christopher S Kang; Michael F Rotondo; Michael C Chang; Leonard J Weireter; Michael Coburn; Robert J Winchell; Ronald M Stewart
Journal:  Trauma Surg Acute Care Open       Date:  2018-01-13

9.  Evidence-based approach to the trauma patient in extremis: Transitioning from exclusive emergency department thoracotomy use to protocolized approaches incorporating resuscitative endovascular balloon occlusion of the aorta.

Authors:  M Chance Spalding; Peter G Thomas; M Shay O'Mara; Christine L Ramirez; Franz S Yanagawa; Heidi H Hon; Brian A Hoey; William S Hoff; James Cipolla; Stanislaw P Stawicki
Journal:  Int J Crit Illn Inj Sci       Date:  2018 Apr-Jun

10.  Effect of resuscitative endovascular balloon occlusion of the aorta in hemodynamically unstable patients with multiple severe torso trauma: a retrospective study.

Authors:  Hiroyuki Otsuka; Toshiki Sato; Keiji Sakurai; Hiromichi Aoki; Takeshi Yamagiwa; Shinichi Iizuka; Sadaki Inokuchi
Journal:  World J Emerg Surg       Date:  2018-10-25       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.